STAT+: FDA warns GLP-1 drugs carry potential risk of rare eye condition
The FDA on Monday warned that GLP-1 drugs carry a potential risk for a rare but serious eye condition that's sometimes referred to as an "eye
DO
By Daniel Okafor · Regulatory Correspondent
Nov 9 10:56 ETSource: STAT
From the source
Read at statnews.comSTAT+: FDA warns GLP-1 drugs carry potential risk of rare eye condition
The FDA on Monday warned that GLP-1 drugs carry a potential risk for a rare but serious eye condition that's sometimes referred to as an "eye stroke."
